JNJ-4306
/ J&J
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 27, 2026
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
(clinicaltrials.gov)
- P1 | N=280 | Recruiting | Sponsor: Janssen Research & Development, LLC | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Chronic Lymphocytic Leukemia • Hematological Malignancies • Lymphoma • Myelodysplastic Syndrome • Oncology
1 to 1
Of
1
Go to page
1